Exact Mass: 761.3682825999999

Lividomycin

C29H55N5O18 (761.354193)

C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

Lividomycin A

C29H55N5O18 (761.354193)

A member of the class of lividomycins that is lividomycin B in which position 4 of the diamino-L-idopyranosyl moiety has been converted into its alpha-D-mannopyranoside. C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic

meehanine L

C37H51N3O14 (761.3370866)

pullularin C

C41H55N5O9 (761.399958)

5alpha-acetyloxy-8alpha-benzoyloxy-15beta-hydroxy-7beta-isobutanoyloxy-9alpha-nicotinyloxy-3beta-propanoyloxyjatropha-6(17),11E-diene-14-one|euphodendrophane H

C42H51NO12 (761.3411086)

C37H47N9O9

C37H47N9O9 (761.3496572)

Y-F-M-R-F-NH2

C38H51N9O6S (761.3682825999999)

3,6-bis(dimethylamino)-10-{4-oxo-4-[(5-{[5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl]amino}pentyl)amino]butyl}acridinium perchlorate

C36H52ClN7O7S (761.3337272000001)

LNAPS 34:9;O

C40H60NO11P (761.3903779999999)

PS 20:1/11:3;O3

C37H64NO13P (761.4115064)

PS 22:6/12:3;O

C40H60NO11P (761.3903779999999)

PS 31:4;O3

C37H64NO13P (761.4115064)

PS 34:9;O

C40H60NO11P (761.3903779999999)

HAEGTFT

C33H47N9O12 (761.3344022)

HAEGTFT is the first N-terminal 1-7 residues of GLP-1 peptide.

TFLLR-NH2(TFA)

C33H54F3N9O8 (761.404724)

TFLLR-NH2 (TFA) is a selective PAR1 agonist with an EC50 of 1.9 μM.

2-{[5-amino-2-(aminomethyl)-6-({5-[(3,5-diamino-2-{[3-amino-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-hydroxycyclohexyl)oxy]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl}oxy)-4-hydroxyoxan-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C29H55N5O18 (761.354193)

3-({2-[(2-{[1,3-dihydroxy-2-({1,3,5-trihydroxy-5-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]pentylidene}amino)butylidene]amino}-1,3-dihydroxypropylidene)amino]-1,3-dihydroxypropylidene}amino)-6,7-dihydroxy-1,1-dimethyl-3,4-dihydro-2h-quinolin-1-ium

[C35H49N6O13]+ (761.3357444000001)

15-benzyl-1,7-dihydroxy-3-(hydroxymethyl)-6-isopropyl-5,11,12-trimethyl-9-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclooctadecane-4,10,13,16-tetrone

C41H55N5O9 (761.399958)

2-({2-[(2-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-n-methylpropanamido}-1-hydroxy-4-methylpentylidene)amino]-1-hydroxy-3-(4-hydroxyphenyl)propylidene}amino)-3-(4-hydroxyphenyl)propanoic acid

C38H56ClN5O9 (761.3766356)

3-{[(2s)-2-{[(2r)-2-{[(2s,3r)-1,3-dihydroxy-2-({1,3,5-trihydroxy-5-[2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]pentylidene}amino)butylidene]amino}-1,3-dihydroxypropylidene]amino}-1,3-dihydroxypropylidene]amino}-6,7-dihydroxy-1,1-dimethyl-3,4-dihydro-2h-quinolin-1-ium

[C35H49N6O13]+ (761.3357444000001)

(3s)-3-{[(2s)-2-{[(2r)-2-{[(2s,3r)-1,3-dihydroxy-2-{[(3r)-1,3,5-trihydroxy-5-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]pentylidene]amino}butylidene]amino}-1,3-dihydroxypropylidene]amino}-1,3-dihydroxypropylidene]amino}-6,7-dihydroxy-1,1-dimethyl-3,4-dihydro-2h-quinolin-1-ium

[C35H49N6O13]+ (761.3357444000001)

2-[(2-{[(1-{2-[(3-amino-10-chloro-1,2-dihydroxydecylidene)amino]-3-hydroxybutanoyl}pyrrolidin-2-yl)(hydroxy)methylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene)amino]-3-(4-hydroxyphenyl)propanoic acid

C37H52ClN5O10 (761.3402522)

[(2r,3s,4s,5r,6s)-6-{[(2s,3r,4r,5r,6s)-2-{4-[(2s,11r)-11-(acetyloxy)-4-hydroxy-1,5,9-triazacyclotridec-4-en-2-yl]phenoxy}-4,5-dihydroxy-6-methyloxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl benzoate

C37H51N3O14 (761.3370866)

(3s)-3-{[(2s)-2-{[(2r)-2-{[(2s,3r)-2-{[(3r)-1,3-dihydroxy-4-[(4s,5s)-4-(hydroxymethyl)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-5-yl]butylidene]amino}-1,3-dihydroxybutylidene]amino}-1,3-dihydroxypropylidene]amino}-1,3-dihydroxypropylidene]amino}-6,7-dihydroxy-1,1-dimethyl-3,4-dihydro-2h-quinolin-1-ium

[C35H49N6O13]+ (761.3357444000001)

{6-[(2-{4-[11-(acetyloxy)-4-hydroxy-1,5,9-triazacyclotridec-4-en-2-yl]phenoxy}-4,5-dihydroxy-6-methyloxan-3-yl)oxy]-3,4,5-trihydroxyoxan-2-yl}methyl benzoate

C37H51N3O14 (761.3370866)

3-{[(2s)-2-{[(2r)-2-{[(2s,3r)-2-({1,3-dihydroxy-4-[4-(hydroxymethyl)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-5-yl]butylidene}amino)-1,3-dihydroxybutylidene]amino}-1,3-dihydroxypropylidene]amino}-1,3-dihydroxypropylidene]amino}-6,7-dihydroxy-1,1-dimethyl-3,4-dihydro-2h-quinolin-1-ium

[C35H49N6O13]+ (761.3357444000001)

(3s,6s,9s,12s,15r,20as)-15-benzyl-1,7-dihydroxy-3-(hydroxymethyl)-6-isopropyl-5,11,12-trimethyl-9-({4-[(3-methylbut-2-en-1-yl)oxy]phenyl}methyl)-3h,6h,9h,12h,15h,18h,19h,20h,20ah-pyrrolo[1,2-d]1-oxa-4,7,10,13,16-pentaazacyclooctadecane-4,10,13,16-tetrone

C41H55N5O9 (761.399958)

(3s)-3-{[(2s)-2-{[(2r)-2-{[(2s,3r)-1,3-dihydroxy-2-{[(3r,5s)-1,3,5-trihydroxy-5-[(4s)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-4-yl]pentylidene]amino}butylidene]amino}-1,3-dihydroxypropylidene]amino}-1,3-dihydroxypropylidene]amino}-6,7-dihydroxy-1,1-dimethyl-3,4-dihydro-2h-quinolin-1-ium

[C35H49N6O13]+ (761.3357444000001)

3-({2-[(2-{[2-({1,3-dihydroxy-4-[4-(hydroxymethyl)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-5-yl]butylidene}amino)-1,3-dihydroxybutylidene]amino}-1,3-dihydroxypropylidene)amino]-1,3-dihydroxypropylidene}amino)-6,7-dihydroxy-1,1-dimethyl-3,4-dihydro-2h-quinolin-1-ium

[C35H49N6O13]+ (761.3357444000001)

(2s)-2-{[(2r)-2-{[(2s)-2-[(2-{[2-({[(2s)-1-[(2r)-2-{[(2s)-2-amino-1-hydroxy-4-methylpentylidene]amino}-3-sulfanylpropanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxyethylidene]amino}-1-hydroxyethylidene)amino]-1-hydroxy-3-(c-hydroxycarbonimidoyl)propylidene]amino}-1-hydroxy-3-sulfanylpropylidene]amino}-3-methylbutanoic acid

C30H51N9O10S2 (761.3200146)

(3s)-3-{[(2s)-2-{[(2r)-2-{[(2s,3r)-2-{[(3r)-1,3-dihydroxy-4-[(4r,5s)-4-(hydroxymethyl)-2-(2-hydroxyphenyl)-4,5-dihydro-1,3-oxazol-5-yl]butylidene]amino}-1,3-dihydroxybutylidene]amino}-1,3-dihydroxypropylidene]amino}-1,3-dihydroxypropylidene]amino}-6,7-dihydroxy-1,1-dimethyl-3,4-dihydro-2h-quinolin-1-ium

[C35H49N6O13]+ (761.3357444000001)